European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

The Sokal and Hasford scores were developed in the chemotherapy and interferon era and are widely used as prognostic indicators in patients with chronic myeloid leukemia (CML). Recently, a new European Treatment and Outcome Study (EUTOS) scoring system was developed. We performed a multicenter retro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Sci
Glavni autori: Yamamoto, Eri, Fujisawa, Shin, Hagihara, Maki, Tanaka, Masatsugu, Fujimaki, Katsumichi, Kishimoto, Kumiko, Hashimoto, Chizuko, Itabashi, Megumi, Ishibashi, Daisuke, Nakajima, Yuki, Tachibana, Takayoshi, Kawasaki, Rika, Kuwabara, Hideyuki, Koharazawa, Hideyuki, Yamazaki, Etsuko, Tomita, Naoto, Sakai, Rika, Fujita, Hiroyuki, Kanamori, Heiwa, Ishigatsubo, Yoshiaki
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2014
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4317875/
https://ncbi.nlm.nih.gov/pubmed/24450386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12321
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items